Description
<p><span style="color: rgb(44, 42, 41);">Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University, talks with regular contributor Amal Shibli Rahhal, MD, from the University of Iowa, and guest expert Thomas Weber, MD, from Duke Health. Together, they discuss </span><a href="https://doi.org/10.1210/clinem/dgaf569" rel="noopener noreferrer" target="_blank" style="color: rgb(0, 45, 114);"><strong>“Anti-fracture efficacy of 5 or 10 yearly zoledronate in women aged 50 to 60 years,”</strong></a><span style="color: rgb(44, 42, 41);"> published in the April 2026 issue of JCEM, and consider how these findings may inform decisions around early treatment strategies, risk assessment, and long-term fracture prevention in clinical practice.</span></p>